News

Axelyf, a biotechnology company focused on RNA therapeutics, has secured $2.6 million in seed financing to further develop its proprietary lipid...

Some of the best links we picked up around the internet

A plasmid-delivered prime editing strategy corrected the glucose-6-phosphate dehydrogenase (G6PD) Viangchan (c.871G>A) mutation in engineered HEK293T...

Some of the best links we picked up around the internet

The latest clinical update includes dosing announcements for two trials, with the first patients now treated with Epicrispr Biotechnologies’ EPI-321...

Some of the best links we picked up around the internet

We’re excited to announce a strategic partnership between CRISPR Medicine News (CMN) and EDUGENE - coming together to advance CRISPR and biotechnology...

CRISPR-Cas12b technology was used to edit allogeneic donor islet cells for transplantation into a man with long-standing type 1 diabetes....